CoQ10 100 mg

CoQ10 100 mg

Metabolic Maintenance4.8 (110 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$38.00 $0.63 per serving

Product analysis

61 out of 100

CoQ10 100 mg combines possible support for blood-vessel function with vitamin C for normal nutrition. Vitamin C may help tiredness when intake is low, while CoQ10 fatigue benefits remain uncertain.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Both ingredient forms are identified, allowing clear preparation comparisons. Their names alone do not establish a quality or absorption advantage.

Ingredient Transparency100

Both ingredient amounts and forms are disclosed. That makes it easy to compare the CoQ10 and vitamin C contributions with other options.

Value For Money40

The CoQ10 contribution offers limited value at the full serving cost. The separate value of the vitamin C contribution remains uncertain.

Customer Satisfaction74

Customer feedback is very positive. A little over a hundred ratings provide a smaller base than widely reviewed alternatives.

Product Focus69

CoQ10 supplies the main possible blood-vessel benefits, while vitamin C adds nutritional support. Fatigue benefits are limited and depend partly on the reason for tiredness.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.63
Customer rating
4.8 · 110 ratings
Report analysis

Goals

Metabolism Support
Impact
Moderate effect
C- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 helps transfer electrons in mitochondria, the parts of cells involved in making usable energy. That role doesn't show that taking it makes your whole body burn more calories. Changes in metabolic markers are a different outcome, so whether this serving increases everyday energy expenditure remains unclear.

How this product is rated for Metabolism Support

Ingredient fit59

Coenzyme Q10 participates in mitochondrial energy production, without a clear general increase in calorie burning.
Goal fit
Coenzyme Q10 participates in mitochondrial energy production, without a clear general increase in calorie burning.
Dose adequacy
The serving provides Coenzyme Q-10 100 mg. These amounts alone don't predict an increase in calorie burning.

Pathways17

The relevant connection is stimulation of energy use, with the size and persistence of any effect uncertain.
Depth
The relevant connection is stimulation of energy use, with the size and persistence of any effect uncertain.
Breadth
The connection is limited to stimulation of energy use, rather than several distinct effects on calorie burning.

Evidence75

Coenzyme Q10 participates in mitochondrial energy production, without a clear general increase in calorie burning.
Evidence strength
Coenzyme Q10 participates in mitochondrial energy production, without a clear general increase in calorie burning.
Studied preparation
The declared ingredient forms match the relevant preparation descriptions; this alone does not predict the size of a benefit.

Formulation logic100

No particular ingredient conflict or missing required partner is identified.
Partner coverage
No required companion ingredient is missing for the ingredient roles described here.
Conflicts
No particular ingredient conflict is identified.
Effective doses
Declared amounts allow comparison, but a dose reference is not a minimum effective amount for increasing calorie burning.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg supports mitochondrial energy production and antioxidant activity. Vitamin C at 120 mg supports normal collagen formation and can help cover a dietary gap. The supplied skin-aging findings use a particular CoQ10 preparation and do not establish general lifespan benefit.

How this product is rated for Longevity

Ingredient fit73

The assessed ingredient mix is relatively focused on the goal’s biological processes. The counted amounts provide partial support relative to the supplied dose ranges.
Goal fit
The assessed ingredient mix is relatively focused on the goal’s biological processes.
Dose adequacy
The counted amounts provide partial support relative to the supplied dose ranges.

Pathways10

The strongest assessed connection is mitochondrial energy production, with limited coverage. No mechanism reaches the saved broader-coverage threshold.
Depth
The strongest assessed connection is mitochondrial energy production, with limited coverage.
Breadth
No mechanism reaches the saved broader-coverage threshold.

Evidence30

Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension. The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Evidence strength
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension.
Studied preparation
The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.

Formulation logic100

The counted ingredients can contribute independently or have their required partner. No ingredient conflict was identified in the saved assessment. 1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflict was identified in the saved assessment.
Effective doses
1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Study evidence
Vitamin C Supportive 30 studies
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mgVitamin C · 120 mg

CoQ10 has limited human findings for blood pressure, lipids and the function of blood-vessel linings, mainly in adults with abnormal lipid levels. This product provides 100 mg of declared CoQ10 per serving. Its ubiquinone form is recognized without establishing superiority over other forms. These marker findings do not establish prevention of heart attacks or strokes.

How this product is rated for Cardiovascular Support

Ingredient fit86

CoQ10 is the sole counted ingredient with a direct connection to cardiovascular markers.
Goal fit
CoQ10 is the sole counted ingredient with a direct connection to cardiovascular markers.
Dose adequacy
The 100 mg serving receives substantial partial amount recognition compared with the supplied study exposure.

Pathways53

The strongest route concerns the function of blood-vessel linings.
Depth
The strongest route concerns the function of blood-vessel linings.
Breadth
Only the vessel-lining route reaches substantial coverage; lipid and other routes are not independently covered.

Evidence88

CoQ10 has limited marker findings in selected populations, rather than established cardiovascular-event prevention.
Evidence strength
CoQ10 has limited marker findings in selected populations, rather than established cardiovascular-event prevention.
Studied preparation
The declared CoQ10 preparation is recognized; no superior delivery-form effect is inferred.

Formulation logic100

No required partner is missing, and none of the checked conflicts was triggered.
Partner coverage
The credited ingredients can contribute without a missing required partner.
Conflicts
No checked stimulant or high-sodium conflict was triggered.
Effective doses
CoQ10 meets the inclusion threshold; vitamin C is below it.
Study evidence
Vitamin C Supportive 101 studies
Heart Health
Impact
High effect
B- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 has a limited connection to blood-vessel function, with mixed blood-pressure and lipid findings in selected populations. The 100 mg serving is below the supplied positive trial's 120 mg exposure. Its amount therefore contributes partially to the saved vascular finding. This does not establish cardiovascular-event prevention or delivery-form superiority.

How this product is rated for Heart Health

Ingredient fit72

CoQ10 provides the relevant vascular connection within the formula. The 100 mg CoQ10 serving is below the supplied 120 mg trial exposure.
Goal fit
CoQ10 provides the relevant vascular connection within the formula.
Dose adequacy
The 100 mg CoQ10 serving is below the supplied 120 mg trial exposure.

Pathways53

The saved findings concentrate on blood-vessel widening.
Depth
Conventional CoQ10 supplies a partial finding on blood-vessel function.
Breadth
Only the vascular aspect meets the coverage criterion.

Evidence98

Conventional CoQ10 has mixed findings for blood pressure and lipids. The ordinary oral CoQ10 preparation is accepted, without a delivery bonus.
Evidence strength
Conventional CoQ10 has mixed findings for blood pressure and lipids.
Studied preparation
The ordinary oral CoQ10 preparation is accepted, without a delivery bonus.

Formulation logic100

No missing required partner or specified ingredient conflict was identified. The counted amounts meet the minimum criterion.
Partner coverage
The counted ingredients have no missing required partner.
Conflicts
No specified ingredient conflict was identified in the supplied facts.
Effective doses
All counted ingredients meet the minimum amount criterion; this does not establish a clinical benefit.
Study evidence
Energy
Impact
High effect
B Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 in the ubiquinone form has limited support for fatigue relief, distinct from an immediate alertness effect. Its role in cellular energy production does not by itself prove a noticeable energy boost, and clinical disease findings do not transfer to routine healthy use. The serving falls short of the full saved amount comparison. Vitamin C can help fatigue associated with low intake, without establishing added energy once intake is adequate.

How this product is rated for Energy

Ingredient fit77

Coenzyme Q-10 anchors the recognized ingredient fit, with declared amounts partly meeting the saved comparisons.
Goal fit
Coenzyme Q-10 is central to the product’s recognized energy connection, although the product is also linked to other goals.
Dose adequacy
The declared amounts partly meet the saved comparisons, limiting the size of the recognized contribution.

Pathways17

The saved coverage is concentrated in mitochondrial energy production.
Depth
The strongest saved coverage concerns mitochondrial energy production; this does not independently prove a noticeable energy benefit.
Breadth
No energy pathway reaches the saved breadth threshold.

Evidence84

Coenzyme Q-10 leads the recognized evidence, but the supplied context limits how broadly its findings apply.
Evidence strength
Coenzyme Q-10 supplies the strongest recognized evidence here, subject to the population and application limits described for it.
Studied preparation
The saved findings accept the qualifying preparations; this does not establish form superiority.

Formulation logic100

No required partner is missing, and no configured sedative conflict is present. The recognized amounts reach the saved minimum comparison.
Partner coverage
The recognized ingredients have no missing required partner for their assigned contributions.
Conflicts
No configured sedative conflict applies: valerian, kava, qualifying tryptophan and melatonin are absent.
Effective doses
All recognized ingredients reach the saved minimum amount comparison; that threshold is not proof of a clinical energy effect.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mgVitamin C · 120 mg

Coenzyme Q10 in its ubiquinone form relates to oxidative and mitochondrial stress. A small trial in statin-treated people with coronary artery disease found a change in one inflammatory marker, while others were unchanged; this does not establish routine clinical benefit. Its 100 mg per serving is below the reviewed 300 mg/day exposure.

How this product is rated for Inflammation

Ingredient fit66

The relevant ingredient is the focus of the declared active ingredients, although the product is linked to several goals. The ubiquinone serving falls below the reviewed 300 mg/day regimen, limiting the exposure match.
Goal fit
The relevant ingredient is the focus of the declared active ingredients, although the product is linked to several goals.
Dose adequacy
The ubiquinone serving falls below the reviewed 300 mg/day regimen, limiting the exposure match.

Pathways13

The strongest recorded connection is oxidative and mitochondrial stress, with limited coverage in the saved comparison. No route reaches the breadth threshold.
Depth
The strongest recorded connection is oxidative and mitochondrial stress, with limited coverage in the saved comparison.
Breadth
No pathway reaches the saved comparison’s breadth threshold, so the ingredient’s connection remains narrow.

Evidence93

Ubiquinone supplies the strongest recorded human-evidence contribution. The reviewed finding concerns selected inflammatory markers in statin-treated coronary artery disease.
Evidence strength
Ubiquinone supplies the strongest recorded human-evidence contribution.
Studied preparation
The counted preparations match those recognized in the saved comparison; this does not establish equivalent clinical results.

Formulation logic100

Partner requirements are met and no configured conflict was recorded. The counted ingredients reach the saved amount threshold.
Partner coverage
The counted ingredients can stand alone or have the partners required by the saved comparison; no added benefit from combining them is established.
Conflicts
No configured ingredient conflict was recorded; this finding is limited to the interactions checked.
Effective doses
The counted ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Study evidence
Vitamin C Supportive 50 studies

Ingredients

IngredientAmount per servingScore
Vitamin C (Ascorbic Acid)
120 mg
CoEnzyme Q10 (Ubiquinone)
100 mg 60
Gluten Free Adults 18–50 Dairy Free
Report overview
D Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyD- Value
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis.
    Rozemeijer S; Hemilä H; van Baaren M; de Man AME · BMC cardiovascular disorders · 2023
    Meta-analysis872 participants7 studies pooledCardiovascular Support forVitamin C
  7. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A · Circulation · 1998
    Clinical trial49 participantsCardiovascular Support forVitamin C
  8. Vitamin C supplementation improves blood pressure and oxidative stress after acute exercise in patients with poorly controlled type 2 diabetes mellitus: A randomized, placebo-controlled, cross-over study.
    Boonthongkaew C; Tong-Un T; Kanpetta Y; Chaungchot N; Leelayuwat C; Leelayuwat N · The Chinese journal of physiology · 2021
    Randomized trial24 participantsCardiovascular Support forVitamin C
  9. Vascular benefits of vitamin C supplementation against fine particulate air pollution in healthy adults: A double-blind randomised crossover trial.
    Ren J; Liang J; Wang J; Yin B; Zhang F; Li X; Zhu S; Tian H; Cui Q; Song J; Liu G; Ling W; Ma Y · Ecotoxicology and environmental safety · 2022
    Randomized trial58 participantsCardiovascular Support forVitamin C
  10. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes.
    Mullan BA; Young IS; Fee H; McCance DR · Hypertension (Dallas, Tex. : 1979) · 2003
    Randomized trial30 participantsCardiovascular Support forVitamin C
  11. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  12. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  13. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  14. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  15. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  16. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  17. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  18. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  19. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  20. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10